Wire Stories
Humanigen Announces $80 Million Loan Facility from Hercules Capital
Company intends to use funds to support lenzilumab manufacturing and commercialization BURLINGAME, Calif.–(BUSINESS WIRE)–Humanigen, Inc. (Nasdaq: HGEN) (�Humanigen�), a clinical stage biopharmaceutical...